Market statusEarly Stage Concept

Products 41 to 50 of 69

Medusoid: Tissue-Engineered Biomimetic Jellyfish by Harvard University + Caltech
Biotech components: Animal
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Research + Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: N/A
Funding types: University
Industry: Health
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical (Device)
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (2 years ago)
Date last modified: 2019/09/13 11:47 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy + Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Fuel and Energy + Chemical
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (2 years ago)
Date last modified: 2019/09/16 16:29 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy + Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Fuel and Energy + Chemical
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (2 years ago)
Date last modified: 2019/09/13 11:47 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Chemical + Other (Industrial)
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Molecule
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (4 months ago)
Date last modified: 2020/12/18 14:39 (4 months ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medicine + Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: N/A
Micro-algae fatty acids by Flinders University
Biotech components: Microbe
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (4 months ago)
Date last modified: 2020/12/18 14:39 (4 months ago)
Known funding amount: N/A
Funding types: University
Industry: Food & Agriculture + Health
Market status: Early Stage Concept
Organization type(s): University
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: N/A
Microbial Fuel Cells by Lebônê
Biotech components: Microbe
Business models: B2C
Country of production: South Africa
Country of distribution: Namibia
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2019/05/15 15:40 (2 years ago)
Known funding amount: 300,000 USD
Funding types: Development Bank + Foundation
Industry: Industrial
Market status: Early Stage Concept + No longer on the market
Organization type(s): Private Company
Product categories: Fuel and Energy
Production process: Open Release
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
NanoHeal by RISE PFI AS
Biotech components: Molecule
Business models: B2B
Country of production: Norway
Country of distribution: Norway
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/10/08 14:51 (3 years ago)
Known funding amount: N/A
Funding types: Government + University
Industry: Health
Market status: Early Stage Concept
Organization type(s): Research Institution
Product categories: Medical Treatment
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Non-browning avocado by Intrexon
Biotech components: Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:31 (2 years ago)
Date last modified: 2019/09/12 14:31 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Non-browning cherries by Intrexon
Biotech components: Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:10 (2 years ago)
Date last modified: 2019/09/12 15:10 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product